ClinicalTrials.govpublic full text
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
atopic dermatitis (ad), randomized double-masked (blind) placebo-controlled trial, t helper 2 (th2) effect, cutaneous microbial community, skin barrier, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837808
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.